Germany
Accomplished track record of leading complex global projects from early pipeline projects to launches. Influencing cross-functional teams and get things done, driving business results and elevating organizational performance. As an enthusiastic leader, I have demonstrated the ability to cultivate and inspire high-performing teams, often employing an informal atmosphere and a sprinkle of humour. I find energy collaborating with people for inspiration and challenge. People say that I am known for my calm and composed approach when navigating complex challenges. I leverage my scientific background to drive strategic decision-making and bring an analytical perspective to my work. With Novo Nordisk developed and launched OZEMPIC® and RYBELSUS® brands. Commercial Project Director for oral diabetes pipe-line and RYBELSUS®. With AstraZeneca Commercial lead of respiratory/inflammation pipe-line, WORK EXPERIENCE Global Brand Head BOEHRINGER INGELHEIM PHARMA | 2026 - Global Director - Future Projects NOVO NORDISK A/S | 2024 – Now Rybelsus Project Director NOVO NORDISK A/S | 2020 – 2024 Rybelsus Brand Director NOVO NORDISK A/S | 2018 – 2020 Ozempic Associate Brand Director NOVO NORDISK A/S | 2016 – 2018 Senior Global Product Manager, GLP-1 pipeline NOVO NORDISK A/S | 2008 – 2016 Senior Global Manager, Respiratory pipeline ASTRA ZENECA | 2003 – 2008 Global Communication Manager ASTRA ZENECA | 2002 – 2003 Global Publication Manager ASTRA ZENECA | 2000 – 2002 Associate Director, Inflammation Pharmacology ASTRA DRACO AB | 1997 – 2000 Army captain Swedish armed forces | 1987
Obesity & Liver TA
Within GLP-1 pipeline marketing, with primary responsibility for semaglutide.
Emerging respiratory pipeline